Download Files:
RdRP-IN-3
SKU
HY-115730-Get quote
Category Reference compound
Tags Anti-infection;Cell Cycle/DNA Damage, DNA/RNA Synthesis;Influenza Virus, Infection
Products Details
Product Description
– RdRP-IN-3 is a promising anti-influenza agent candidate by inhibiting the activity of RNA-dependent RNA polymerase (RdRp).
Web ID
– HY-115730
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C25H21N3O4
References
– [1]Tang L, et al. Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir. J Med Chem. 2021 Oct 14;64(19):14465-14476.
CAS Number
– 2641299-75-2
Molecular Weight
– 427.45
SMILES
– O=C1N2[C@](COCC2)([H])N(C3C4=CC=CC=C4C=CC5=CC=CC=C35)N6C1=C(O)C(C=C6)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– DNA/RNA Synthesis;Influenza Virus
Pathway
– Anti-infection;Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.